Industrial and infrastructure sectors are undergoing rapid modernisation

In the pharma sector, precision is non-negotiable and compliance is constant. Attention often focuses on formulations and manufacturing processes; yet the foundation of operational excellence lies in infrastructure - the systems that quietly ensure safety, efficiency and regulatory adherence. Jinali Gandhi, Director at Gandhi Automations, represents a new generation of leaders shaping this critical dimension of the industry

- 

How critical is infrastructure automation in pharma facilities?
Infrastructure is integral to maintaining controlled environments. In pharma manufacturing, environmental stability is directly linked to product quality and regulatory adherence. Access systems must support air pressure control, thermal insulation, contamination prevention, and secure material flow.

Automation strengthens this framework. Rapid-action doors reduce air exchange in classified zones, insulated closures help maintain stringent temperature parameters, and sealed loading bays protect sensitive products during dispatch. By minimising manual dependency and ensuring operational consistency, automated systems enhance reliability across the facility.

In pharma, infrastructure is not peripheral — it is a compliance enabler.

What differentiates pharma infrastructure from other industrial sectors?